Stock SURG SURGEPAYS
Add to a list
To use this feature you must be a member
Log inSign up

Consensus SURGEPAYS OTC Markets

Equities

SURG

US86882L1052

End-of-day quote OTC Markets
Other stock markets
 04:30:00 23/12/2021 am IST 		5-day change 1st Jan Change
2.31 USD +4.05% Intraday chart for SURGEPAYS +4,826.94% -.--%
13/05 SurgePays Q1 Earnings, Revenue Fall MT
13/05 Transcript : SurgePays, Inc., Q1 2024 Earnings Call, May 13, 2024

Evolution of the average Target Price on SURGEPAYS

Price target over the last 5 years

History of analyst recommendation changes

a5.ATv0dbveniCG-7JAb2xlPIN0yyr6yXDvj8Ry7D6803M.S17HEvK0x0_FvsgNAlUrcfI182yt_TSW4pxLhmnTuSF4Da4l9u7BR-2thg~58324e473d8b2a21476c22b692c1528b

Analyst Recommendations on SURGEPAYS

Ascendiant Capital Adjusts SurgePays' Price Target to $10 From $11.50, Keeps Buy Rating MT
Maxim Downgrades SurgePays to Hold From Buy MT
Maxim Raises SurgePays Price Target to $10 From $8, Maintains Buy Rating MT
Maxim Adjusts SurgePays' Price Target to $8 From $6, Reiterates Buy Rating MT
Maxim Starts SurgePays at Buy with $6 Price Target MT
Ascendiant Capital Starts SurgePays at Buy With $7 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
3.4 USD
Average target price
6.75 USD
Spread / Average Target
+98.53%
High Price Target
9.5 USD
Spread / Highest target
+179.41%
Low Price Target
4 USD
Spread / Lowest Target
+17.65%

Consensus detail

Consensus revision (last 18 months)

Analysts covering SURGEPAYS

Ascendiant Capital
Maxim

Ratings for SURGEPAYS

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. SURG Stock
  4. SURG Stock
  5. Consensus SURGEPAYS